Ausgabe 6/2017
Inhalt (15 Artikel)
Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer
A. Valentino, P. Reclusa, R. Sirera, M. Giallombardo, C. Camps, P. Pauwels, S. Crispi, C. Rolfo
Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it
M. Drizou, E. A. Kotteas, N. Syrigos
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
M. Hidalgo, R. Álvarez, J. Gallego, C. Guillén-Ponce, B. Laquente, T. Macarulla, A. Muñoz, M. Salgado, R. Vera, J. Adeva, I. Alés, S. Arévalo, J. Blázquez, A. Calsina, A. Carmona, E. de Madaria, R. Díaz, L. Díez, T. Fernández, B. G. de Paredes, M. E. Gallardo, I. González, O. Hernando, P. Jiménez, A. López, C. López, F. López-Ríos, E. Martín, J. Martínez, A. Martínez, J. Montans, R. Pazo, J. C. Plaza, I. Peiró, J. J. Reina, A. Sanjuanbenito, R. Yaya, Alfredo Carrato
Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology
P. Pérez-Segura, J. E. Palacio, L. Vázquez, S. Monereo, R. de las Peñas, P. Martínez de Icaya, C. Grávalos, A. Lecube, A. Blasco, J. M. García-Almeida, I. Barneto, A. Goday
miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC
L. Chang, K. Li, T. Guo
Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients
I. Barco, C. Chabrera, A. García-Fernández, M. Fraile, S. González, L. Canales, J. M. Lain, C. González, M. C. Vidal, E. Vallejo, J. Deu, A. Pessarrodona, N. Giménez, M. García Font
Neutrophil to lymphocyte ratio associated with prognosis of lung cancer
V. Bar-Ad, J. Palmer, L. Li, Y. Lai, B. Lu, R. E. Myers, Z. Ye, R. Axelrod, J. M. Johnson, M. Werner-Wasik, S. W. Cowan, N. R. Evans, B. T. Hehn, C. C. Solomides, C. Wang
High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab
S. S. Kumar, Y. Tomita, J. Wrin, M. Bruhn, A. Swalling, M. Mohammed, T. J. Price, J. E. Hardingham
Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines
J. Capellades, P. Teixidor, G. Villalba, C. Hostalot, G. Plans, R. Armengol, S. Medrano, A. Estival, R. Luque, S. Gonzalez, M. Gil-Gil, S. Villa, J. Sepulveda, J. J. García-Mosquera, C. Balana
A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma
W. Zhao, C. Sun, Z. Cui
The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma
H. Yin, M. E, H. Zhang, C. Wang
Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis
G. Zu, T. Zhang, W. Li, Y. Sun, X. Zhang
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program
M. González-Cao, A. Arance, J. M. Piulats, I. Marquez-Rodas, J. L. Manzano, A. Berrocal, G. Crespo, D. Rodriguez, E. Perez-Ruiz, M. Berciano, A. Soria, A. G. Castano, E. Espinosa, C. Montagut, L. Alonso, T. Puertolas, C. Aguado, M. A. Royo, R. Blanco, J. F. Rodríguez, E. Muñoz, P. Mut, F. Barron, S. Martin-Algarra
Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors
I. Pajares Bernad, J. Martínez Trufero, L. Calera Urquizu, R. A. Pazo Cid, A. Cebollero de Miguel, M. J. Agustin, M. Lanzuela, A. Antón
Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area
J. García-Lorenzo, N. Farre, A. Codina, O. Gallego, M. De Vega, X. León